Estee Lauder (EL) and other Club holdings with meaningful exposure to the Chinese economy bounced Friday, following news that BioNTech ‘s (BNTX) Covid vaccine will soon be available to foreign residents living in China. We’re cautiously optimistic about the vaccine development , which adds to hopes that Beijing will soften its restrictive pandemic policies after … Read more
Pfizer, BioNTech file for approval of 2nd bivalent COVID-19 vaccine in Switzerland Source link
Dilok Klaisataporn Thirteen of the world’s 20 largest biopharmaceutical companies experienced more than 10% revenue growth from 2020 to 2021, according to a new report. Data and analytics company GlobalData found that overall, the top 20 biopharmas had net revenue of $846.8B, an increase of $166.4B over 2020. The four companies with the largest year-over-year … Read more
Moderna (MRNA) said Friday it’s suing Pfizer (PFE) and BioNTech (BNTX) for patent infringement, claiming the duo copied its messenger RNA technology to make Covid vaccine Comirnaty. In response, all three vaccine stocks fell. X The suit alleges Comirnaty infringes on patents Moderna filed from 2010 to 2016 covering messenger RNA, or mRNA, technology. That … Read more
Moderna sues Pfizer and BioNTech over COVID vaccine – CBS News Watch CBS News Moderna is suing rival drugmakers Pfizer and BioNTech, claiming they copied its technology when developing COVID vaccines. Both Pfizer and Moderna’s shots use mRNA technology, which Moderna says it pioneered. Pfizer says it will “vigorously defend” itself against the allegations. Be … Read more
Moderna is taking Pfizer and Germany’s BioNTech to court, claiming the rival drugmakers copied its technology in developing their COVID-19 vaccine. In documents filed in U.S. District Court in Massachusetts and in Germany, Moderna claims Pfizer and BioNTech violated its intellectual property rights on key parts of its messenger RNA technology, which it had patents … Read more
Text size Moderna is suing Pfizer and BioNTech for patent infringement. Karen Ducey/Getty Images Moderna on Friday launched a battle for control of the future of messenger RNA technology, announcing that it was suing its competitors Pfizer and BioNTech in the U.S. and Germany for patent infringement. In a lawsuit it said it was filing … Read more
BioNTech and Pfizer will start a clinical trial of a Covid-19 vaccine adapted to the BA.4 and BA.5 variants of Omicron this month, as the German biotech forecasts an increase in demand at the end of the year. The company missed sales and earnings expectations in the second quarter after the European Commission renegotiated its … Read more
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October, which will help spur demand in the fourth quarter, the German biotech firm said on Monday as it reaffirmed its vaccine-revenue forecast for the year. Demand for the vaccine, 3.6 billion doses of which have been shipped globally, is waning as most … Read more
Text size BioNTech reiterates its prior 2022 financial full-year outlook . Carlos Osorio/POOL/AFP via Getty Images Shares of BioNTech were falling in premarket trading Monday after the the German biotech company posted earnings and revenue below analysts’ expectations. The company, which partnered with Pfizer (ticker: PFE) to develop the first Covid-19 vaccine approved for use in the … Read more